Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


17.02.2025

1 BJU Int
2 BMC Cancer
1 Br J Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Eur J Radiol
1 Eur Urol
2 Int J Radiat Oncol Biol Phys
3 J Urol
1 Magn Reson Imaging
1 Oncogene
1 PLoS One
1 Prostate
1 Radiol Imaging Cancer
4 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BJU Int

  1. XIE S, Liu J, Shen B, Xu H, et al
    Salvage low-dose vs high-dose brachytherapy for radio-recurrent prostate cancer.
    BJU Int. 2025 Feb 9. doi: 10.1111/bju.16639.
    PubMed         Abstract available


    BMC Cancer

  2. CAO L, He R, Zhang A, Li L, et al
    Development of a deep learning system for predicting biochemical recurrence in prostate cancer.
    BMC Cancer. 2025;25:232.
    PubMed         Abstract available

  3. WEGENER E, Ng M, Guerrieri M, Showalter TN, et al
    A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol.
    BMC Cancer. 2025;25:250.
    PubMed         Abstract available


    Br J Cancer

  4. VAN DER KLEIJ MBA, Meertens M, Groenland SL, Kordes S, et al
    Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.
    Br J Cancer. 2025 Feb 11. doi: 10.1038/s41416-025-02954.
    PubMed         Abstract available


    Cancer Lett

  5. SUBRAMANIAM S, Jeet V, Gunter JH, Clements JA, et al
    Lactoferrin-Encapsulated Dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer.
    Cancer Lett. 2025 Feb 7:217522. doi: 10.1016/j.canlet.2025.217522.
    PubMed         Abstract available


    Clin Cancer Res

  6. BIDKAR AP, Peter R, Wadhwa A, Bobba KN, et al
    Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.
    Clin Cancer Res. 2025 Feb 13. doi: 10.1158/1078-0432.CCR-24-2850.
    PubMed         Abstract available


    Eur J Radiol

  7. PAUSCH AM, Ghafoor S, Notter R, Benke-Bruderer S, et al
    MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS.
    Eur J Radiol. 2025;184:111982.
    PubMed         Abstract available


    Eur Urol

  8. AZAD AA, Kostos L, Agarwal N, Attard G, et al
    Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer.
    Eur Urol. 2025 Feb 12:S0302-2838(25)00023-5. doi: 10.1016/j.eururo.2025.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  9. TWARD J, Lloyd S, Johnson S, Dechet C, et al
    A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiotherapy in Hormone-Naive Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study.
    Int J Radiat Oncol Biol Phys. 2025 Feb 6:S0360-3016(25)00095.
    PubMed         Abstract available

  10. PATEL KR, Spratt DE, Tran PT, Krauss DJ, et al
    The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Feb 6:S0360-3016(25)00086.
    PubMed         Abstract available


    J Urol

  11. AHDOOT M, Naser-Tavakolian A, Heard JR, Williams C, et al
    PSA Density to Select MRI Targeted versus Combined Biopsy for Prostate Cancer Diagnosis: A Secondary Analysis of the Trio Study.
    J Urol. 2025 Feb 14:101097JU0000000000004480. doi: 10.1097/JU.0000000000004480.
    PubMed         Abstract available

  12. MARRA G, Barletta F, Scuderi S, Montefusco G, et al
    Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: a multicenter study.
    J Urol. 2025 Feb 10:101097JU0000000000004468. doi: 10.1097/JU.0000000000004468.
    PubMed         Abstract available

  13. SHORE N
    Reply: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
    J Urol. 2025 Feb 10:101097JU0000000000004439. doi: 10.1097/JU.0000000000004439.
    PubMed        


    Magn Reson Imaging

  14. SHIRAISHI K, Nakaura T, Kobayashi N, Uetani H, et al
    Enhancing thin slice 3D T2-weighted prostate MRI with super-resolution deep learning reconstruction: Impact on image quality and PI-RADS assessment.
    Magn Reson Imaging. 2024;117:110308.
    PubMed         Abstract available


    Oncogene

  15. SCHMIDT MJ, Naghdloo A, Prabakar RK, Kamal M, et al
    Polyploid cancer cells reveal signatures of chemotherapy resistance.
    Oncogene. 2025;44:439-449.
    PubMed         Abstract available


    PLoS One

  16. CEN Y, Feng S, Xu Y, Zhang C, et al
    miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer.
    PLoS One. 2025;20:e0317385.
    PubMed         Abstract available


    Prostate

  17. KAVAK EE, Dilli I
    Progression-Free Survival Prediction Performance of ChatGPT: Analysis With Real Life Data in Early and Locally Advanced Prostate Cancer.
    Prostate. 2025 Feb 13:e24871. doi: 10.1002/pros.24871.
    PubMed         Abstract available


    Radiol Imaging Cancer

  18. SALKA B, Troost JP, Gaur S, Shankar PR, et al
    Clinical and Imaging Predictors of False-Positive and False-Negative Results in Prostate Multiparametric MRI Using PI-RADS Version 2.
    Radiol Imaging Cancer. 2025;7:e240019.
    PubMed         Abstract available


    Urology

  19. RATHI N, Blake Z, Hyman J, Nemirovsky DR, et al
    Castration Levels of Testosterone Results in Atrophy of Androgen-Sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.
    Urology. 2024 Oct 18:S0090-4295(24)00865-3. doi: 10.1016/j.urology.2024.
    PubMed         Abstract available

  20. DAGNINO F, Labban M, Berk B, Qian Z, et al
    Trends and Safety of Same-day Discharge for Robot-assisted Laparoscopic Prostatectomy: A Comparison Between the Pre-pandemic and Pandemic Periods From the National Cancer Database.
    Urology. 2025;196:165-173.
    PubMed         Abstract available

  21. OZTURK E, Ozden E, Isikdogan M, Dagli I, et al
    The Effect of Listening to Music on Pain and Anxiety Scores During Office Based Transperineal Prostate Biopsy: A Prospective Study.
    Urology. 2025;196:254-259.
    PubMed         Abstract available

  22. DE BARROS HA, Downes MR, Droghetti M, Bekers EM, et al
    Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer with and without Synchronous Nodal Metastases at Radical Prostatectomy: Results from a Case-Control Matched, Multicenter Study.
    Urology. 2025 Feb 6:S0090-4295(25)00109-8. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.